-
1
-
-
0035066332
-
Alzheimer’s disease: genes, proteins, and therapy
-
COI: 1:CAS:528:DC%2BD3MXislCrsLc%3D, PID: 11274343
-
Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81:741–766
-
(2001)
Physiol Rev
, vol.81
, pp. 741-766
-
-
Selkoe, D.J.1
-
2
-
-
77953675879
-
Probing the biology of Alzheimer’s disease in mice
-
COI: 1:CAS:528:DC%2BC3cXnvFaksLc%3D, PID: 20547123
-
Ashe KH, Zahs KR (2010) Probing the biology of Alzheimer’s disease in mice. Neuron 66:631–645
-
(2010)
Neuron
, vol.66
, pp. 631-645
-
-
Ashe, K.H.1
Zahs, K.R.2
-
3
-
-
0037135111
-
The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics
-
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 29:353–356
-
(2002)
Science
, vol.29
, pp. 353-356
-
-
Hardy, J.1
Selkoe, D.J.2
-
4
-
-
78650962354
-
Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimers disease
-
COI: 1:CAS:528:DC%2BC3cXhsVektLvL, PID: 20847404
-
Gil-Bea FJ, Solas M, Solomon A, Mugueta C, Winblad B, Kivipelto M et al (2010) Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimers disease. J Alzheimers Dis 22:405–413
-
(2010)
J Alzheimers Dis
, vol.22
, pp. 405-413
-
-
Gil-Bea, F.J.1
Solas, M.2
Solomon, A.3
Mugueta, C.4
Winblad, B.5
Kivipelto, M.6
-
5
-
-
0030915855
-
Oxidative stress hypothesis in Alzheimer’s disease
-
COI: 1:CAS:528:DyaK2sXjtlaqs7o%3D, PID: 9165306
-
Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med 23:134–147
-
(1997)
Free Radic Biol Med
, vol.23
, pp. 134-147
-
-
Markesbery, W.R.1
-
6
-
-
84872580306
-
Insulin and Alzheimer’s disease: untangling the web
-
PID: 22936011
-
Craft S, Cholerton B, Baker LD (2013) Insulin and Alzheimer’s disease: untangling the web. J Alzheimers Dis 33:S263–S275
-
(2013)
J Alzheimers Dis
, vol.33
, pp. S263-S275
-
-
Craft, S.1
Cholerton, B.2
Baker, L.D.3
-
7
-
-
15244344784
-
Insulin signaling, diabetes mellitus and risk of Alzheimer disease
-
PID: 15750216
-
Zhu X, Perry G, Smith MA (2005) Insulin signaling, diabetes mellitus and risk of Alzheimer disease. J Alzheimers Dis 7:81–84
-
(2005)
J Alzheimers Dis
, vol.7
, pp. 81-84
-
-
Zhu, X.1
Perry, G.2
Smith, M.A.3
-
8
-
-
15244350991
-
Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer’s disease
-
PID: 15750214
-
de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer’s disease. J Alzheimers Dis 7:45–61
-
(2005)
J Alzheimers Dis
, vol.7
, pp. 45-61
-
-
de la Monte, S.M.1
Wands, J.R.2
-
9
-
-
15244351255
-
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease-is this type 3 diabetes?
-
COI: 1:CAS:528:DC%2BD2MXhvVSrtL8%3D, PID: 15750215
-
Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R et al (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease-is this type 3 diabetes? J Alzheimers Dis 7:63–80
-
(2005)
J Alzheimers Dis
, vol.7
, pp. 63-80
-
-
Steen, E.1
Terry, B.M.2
Rivera, E.J.3
Cannon, J.L.4
Neely, T.R.5
Tavares, R.6
-
10
-
-
84863724280
-
Alzheimer disease: insulin resistance and AD—extending the translational path
-
COI: 1:CAS:528:DC%2BC38XhtVSgs7zI, PID: 22710630
-
Craft S (2012) Alzheimer disease: insulin resistance and AD—extending the translational path. Nat Rev Neurol 8:360–362
-
(2012)
Nat Rev Neurol
, vol.8
, pp. 360-362
-
-
Craft, S.1
-
11
-
-
0019142890
-
Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases
-
COI: 1:STN:280:DyaL3M7kslWrsg%3D%3D, PID: 6259457
-
Iwangoff P, Armbruster R, Enz A, Meier-Ruge W (1980) Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases. Mech Ageing Dev 14:203–209
-
(1980)
Mech Ageing Dev
, vol.14
, pp. 203-209
-
-
Iwangoff, P.1
Armbruster, R.2
Enz, A.3
Meier-Ruge, W.4
-
12
-
-
84868094595
-
Brain insulin signaling and Alzheimer’s disease: current evidence and future directions
-
PID: 22205300
-
Schiöth HB, Craft S, Brooks SJ, Frey WH II, Benedict C (2012) Brain insulin signaling and Alzheimer’s disease: current evidence and future directions. Mol Neurobiol 46:4–10
-
(2012)
Mol Neurobiol
, vol.46
, pp. 4-10
-
-
Schiöth, H.B.1
Craft, S.2
Brooks, S.J.3
Frey, W.H.4
Benedict, C.5
-
13
-
-
0842328001
-
Update on adipocyte hormones regulation of energy balance and carbohydrate/lipid metabolism
-
COI: 1:CAS:528:DC%2BD2cXhtlGqtrs%3D, PID: 14749280
-
Havel PJ (2004) Update on adipocyte hormones regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53:S143–S151
-
(2004)
Diabetes
, vol.53
, pp. S143-S151
-
-
Havel, P.J.1
-
14
-
-
0026670206
-
Insulin in the brain: a hormonal regulator of energy balance
-
COI: 1:CAS:528:DyaK38XmtVGhtbs%3D, PID: 1425482
-
Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr (1992) Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 13:387–414
-
(1992)
Endocr Rev
, vol.13
, pp. 387-414
-
-
Schwartz, M.W.1
Figlewicz, D.P.2
Baskin, D.G.3
Woods, S.C.4
Porte, D.5
-
15
-
-
0018090354
-
Insulin receptors are widely distributed in the central nervous system of the rat
-
COI: 1:CAS:528:DyaE1cXkvVCqt7g%3D, PID: 205798
-
Havrankova J, Roth J, Brownstein M (1978) Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272:827–829
-
(1978)
Nature
, vol.272
, pp. 827-829
-
-
Havrankova, J.1
Roth, J.2
Brownstein, M.3
-
16
-
-
0014214923
-
Insulin in the cerebrospinal fluid
-
COI: 1:CAS:528:DyaF2sXltFCju78%3D, PID: 6055448
-
Margolis RU, Altszuler N (1967) Insulin in the cerebrospinal fluid. Nature 215:1375–1376
-
(1967)
Nature
, vol.215
, pp. 1375-1376
-
-
Margolis, R.U.1
Altszuler, N.2
-
17
-
-
65649098029
-
Phosphorylation of IRS proteins, insulin action, and insulin resistance
-
COI: 1:CAS:528:DC%2BD1MXkvVyhsbY%3D, PID: 18728222
-
Boura-Halfon S, Zick Y (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 296:E581–E591
-
(2009)
Am J Physiol Endocrinol Metab
, vol.296
, pp. E581-E591
-
-
Boura-Halfon, S.1
Zick, Y.2
-
18
-
-
0035947044
-
Role of insulin and insulin receptor in learning and memory
-
COI: 1:CAS:528:DC%2BD3MXjslSktLc%3D, PID: 11377828
-
Zhao W-Q, Alkon DL (2001) Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 177:125–134
-
(2001)
Mol Cell Endocrinol
, vol.177
, pp. 125-134
-
-
Zhao, W.-Q.1
Alkon, D.L.2
-
19
-
-
0035743089
-
Improving influence of insulin on cognitive functions in humans
-
COI: 1:CAS:528:DC%2BD3MXnsV2gu7k%3D, PID: 11598383
-
Kern W, Peters A, Fruehwald-Schultes B, Deininger E, Born J, Fehm HL (2001) Improving influence of insulin on cognitive functions in humans. Neuroendocrinology 74:270–280
-
(2001)
Neuroendocrinology
, vol.74
, pp. 270-280
-
-
Kern, W.1
Peters, A.2
Fruehwald-Schultes, B.3
Deininger, E.4
Born, J.5
Fehm, H.L.6
-
20
-
-
42249116015
-
Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair
-
COI: 1:CAS:528:DC%2BD1cXls1Sjs7s%3D, PID: 18402935
-
Nelson TJ, Sun M-K, Hongpaisan J, Alkon DL (2008) Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. Eur J Pharmacol 585:76–87
-
(2008)
Eur J Pharmacol
, vol.585
, pp. 76-87
-
-
Nelson, T.J.1
Sun, M.-K.2
Hongpaisan, J.3
Alkon, D.L.4
-
21
-
-
33845695894
-
Intranasal insulin improves memory in humans: superiority of insulin aspart
-
PID: 16936707
-
Benedict C, Hallschmid M, Schmitz K, Schultes B, Ratter F, Fehm HL et al (2006) Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology 32:239–243
-
(2006)
Neuropsychopharmacology
, vol.32
, pp. 239-243
-
-
Benedict, C.1
Hallschmid, M.2
Schmitz, K.3
Schultes, B.4
Ratter, F.5
Fehm, H.L.6
-
22
-
-
0001883841
-
Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restriction
-
Prolla TA, Mattson MP (2001) Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restriction. Trends Neurosci 24:21–31
-
(2001)
Trends Neurosci
, vol.24
, pp. 21-31
-
-
Prolla, T.A.1
Mattson, M.P.2
-
23
-
-
12144290448
-
Role for neuronal insulin resistance in neurodegenerative diseases
-
COI: 1:CAS:528:DC%2BD2cXitlWht7Y%3D, PID: 14981233
-
Schubert M, Gautam D, Surjo D, Ueki K, Baudler S, Schubert D et al (2004) Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci USA 101:3100–3105
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 3100-3105
-
-
Schubert, M.1
Gautam, D.2
Surjo, D.3
Ueki, K.4
Baudler, S.5
Schubert, D.6
-
24
-
-
1842734649
-
Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer’s disease
-
COI: 1:CAS:528:DC%2BD2cXjt1Shsbo%3D, PID: 15094077
-
Watson G, Craft S (2004) Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer’s disease. Eur J Pharmacol 490:97–113
-
(2004)
Eur J Pharmacol
, vol.490
, pp. 97-113
-
-
Watson, G.1
Craft, S.2
-
25
-
-
15444339756
-
Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease
-
PID: 9720972
-
Frölich L, Blum-Degen D, Bernstein H-G, Engelsberger S, Humrich J, Laufer S et al (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease. J Neural Transm 105:423–438
-
(1998)
J Neural Transm
, vol.105
, pp. 423-438
-
-
Frölich, L.1
Blum-Degen, D.2
Bernstein, H.-G.3
Engelsberger, S.4
Humrich, J.5
Laufer, S.6
-
26
-
-
68949089312
-
Alzheimer’s disease is type 3 diabetes—evidence reviewed
-
Suzanne M, Wands JR (2008) Alzheimer’s disease is type 3 diabetes—evidence reviewed. J Diabetes Sci Technol 2:1101–1113
-
(2008)
J Diabetes Sci Technol
, vol.2
, pp. 1101-1113
-
-
Suzanne, M.1
Wands, J.R.2
-
27
-
-
1842785179
-
Glucose metabolism and insulin receptor signal transduction in Alzheimer disease
-
COI: 1:CAS:528:DC%2BD2cXjt1Shsbs%3D, PID: 15094078
-
Hoyer S (2004) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 490:115–125
-
(2004)
Eur J Pharmacol
, vol.490
, pp. 115-125
-
-
Hoyer, S.1
-
28
-
-
33845577779
-
The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer’s Disease
-
COI: 1:CAS:528:DC%2BD2sXhsFantg%3D%3D, PID: 17049785
-
Cole GM, Frautschy SA (2007) The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer’s Disease. Exp Gerontol 42:10–21
-
(2007)
Exp Gerontol
, vol.42
, pp. 10-21
-
-
Cole, G.M.1
Frautschy, S.A.2
-
29
-
-
0029981501
-
Cortical synaptic changes and gliosis in normal aging, Alzheimer’s disease and frontal lobe degeneration
-
COI: 1:STN:280:DyaK28zhtFSktg%3D%3D, PID: 8740626
-
Liu X, Erikson C, Brun A (1996) Cortical synaptic changes and gliosis in normal aging, Alzheimer’s disease and frontal lobe degeneration. Dementia 7:128–134
-
(1996)
Dementia
, vol.7
, pp. 128-134
-
-
Liu, X.1
Erikson, C.2
Brun, A.3
-
30
-
-
3242739968
-
O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer’s disease
-
COI: 1:CAS:528:DC%2BD2cXmtFWmtLs%3D, PID: 15249677
-
Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong C-X (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer’s disease. Proc Natl Acad Sci USA 101:10804–10809
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 10804-10809
-
-
Liu, F.1
Iqbal, K.2
Grundke-Iqbal, I.3
Hart, G.W.4
Gong, C.-X.5
-
31
-
-
0037221379
-
The role of insulin resistance in the pathogenesis of Alzheimer’s disease
-
COI: 1:CAS:528:DC%2BD3sXms1Sjtw%3D%3D, PID: 12467491
-
Watson GS, Craft S (2003) The role of insulin resistance in the pathogenesis of Alzheimer’s disease. CNS Drugs 17:27–45
-
(2003)
CNS Drugs
, vol.17
, pp. 27-45
-
-
Watson, G.S.1
Craft, S.2
-
32
-
-
0842309993
-
Increased risk of type 2 diabetes in Alzheimer disease
-
COI: 1:CAS:528:DC%2BD2cXhtlWgsr8%3D, PID: 14747300
-
Janson J, Laedtke T, Parisi JE, O’Brien P, Petersen RC, Butler PC (2004) Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53:474–481
-
(2004)
Diabetes
, vol.53
, pp. 474-481
-
-
Janson, J.1
Laedtke, T.2
Parisi, J.E.3
O’Brien, P.4
Petersen, R.C.5
Butler, P.C.6
-
33
-
-
33745402341
-
Acetylcholinesterase inhibitors for Alzheimer’s disease: anti-inflammatories in acetylcholine clothing!
-
COI: 1:STN:280:DC%2BD28zntFyhtw%3D%3D, PID: 16788077
-
Tabet N (2006) Acetylcholinesterase inhibitors for Alzheimer’s disease: anti-inflammatories in acetylcholine clothing! Age Ageing 35:336–338
-
(2006)
Age Ageing
, vol.35
, pp. 336-338
-
-
Tabet, N.1
-
34
-
-
79251623365
-
Diabetes mellitus and Alzheimer’s disease: shared pathology and treatment?
-
COI: 1:CAS:528:DC%2BC3MXjvFSnurk%3D, PID: 21284695
-
Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB (2011) Diabetes mellitus and Alzheimer’s disease: shared pathology and treatment? Br J Clin Pharmacol 71:365–376
-
(2011)
Br J Clin Pharmacol
, vol.71
, pp. 365-376
-
-
Akter, K.1
Lanza, E.A.2
Martin, S.A.3
Myronyuk, N.4
Rua, M.5
Raffa, R.B.6
-
35
-
-
0346731030
-
Neuronal thread protein regulation and interaction with microtubule-associated proteins in SH-Sy5y neuronal cells
-
PID: 14685691
-
De la Monte S, Chen G, Rivera E, Wands J (2003) Neuronal thread protein regulation and interaction with microtubule-associated proteins in SH-Sy5y neuronal cells. Cell Mol Life Sci 60:2679–2691
-
(2003)
Cell Mol Life Sci
, vol.60
, pp. 2679-2691
-
-
De la Monte, S.1
Chen, G.2
Rivera, E.3
Wands, J.4
-
36
-
-
84859718265
-
Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
-
COI: 1:CAS:528:DC%2BC38Xlt1egtbY%3D, PID: 22476197
-
Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A et al (2012) Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122:1316–1338
-
(2012)
J Clin Invest
, vol.122
, pp. 1316-1338
-
-
Talbot, K.1
Wang, H.Y.2
Kazi, H.3
Han, L.Y.4
Bakshi, K.P.5
Stucky, A.6
-
37
-
-
33644591150
-
Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: link to brain reductions in acetylcholine
-
COI: 1:CAS:528:DC%2BD2MXht1ynsLjF, PID: 16340083
-
Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: link to brain reductions in acetylcholine. J Alzheimers Dis 8:247–268
-
(2005)
J Alzheimers Dis
, vol.8
, pp. 247-268
-
-
Rivera, E.J.1
Goldin, A.2
Fulmer, N.3
Tavares, R.4
Wands, J.R.5
de la Monte, S.M.6
-
38
-
-
84890839540
-
Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer’s disease
-
PID: 24333407
-
Alagiakrishnan K, Sankaralingam S, Ghosh M, Mereu L, Senior P (2013) Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer’s disease. Discov Med 16:277–286
-
(2013)
Discov Med
, vol.16
, pp. 277-286
-
-
Alagiakrishnan, K.1
Sankaralingam, S.2
Ghosh, M.3
Mereu, L.4
Senior, P.5
-
39
-
-
79952449386
-
Insulin-resistant brain state: the culprit in sporadic Alzheimer’s disease?
-
COI: 1:CAS:528:DC%2BC3MXjtFWjtbw%3D, PID: 21262392
-
Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer’s disease? Ageing Res Rev 10:264–273
-
(2011)
Ageing Res Rev
, vol.10
, pp. 264-273
-
-
Correia, S.C.1
Santos, R.X.2
Perry, G.3
Zhu, X.4
Moreira, P.I.5
Smith, M.A.6
-
40
-
-
36448936053
-
Common pathological processes in Alzheimer disease and type 2 diabetes: a review
-
COI: 1:CAS:528:DC%2BD2sXhsVSrsr%2FK, PID: 17920690
-
Li L, Hölscher C (2007) Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 56:384–402
-
(2007)
Brain Res Rev
, vol.56
, pp. 384-402
-
-
Li, L.1
Hölscher, C.2
-
41
-
-
70449732132
-
Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer’s disease and diabetes mellitus
-
COI: 1:CAS:528:DC%2BD1MXhsVGms7nP, PID: 19778613
-
Valente T, Gella A, Fernàndez-Busquets X, Unzeta M, Durany N (2010) Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer’s disease and diabetes mellitus. Neurobiol Dis 37:67–76
-
(2010)
Neurobiol Dis
, vol.37
, pp. 67-76
-
-
Valente, T.1
Gella, A.2
Fernàndez-Busquets, X.3
Unzeta, M.4
Durany, N.5
-
42
-
-
0037153158
-
A central role for JNK in obesity and insulin resistance
-
COI: 1:CAS:528:DC%2BD38XovVekt7g%3D, PID: 12447443
-
Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K et al (2002) A central role for JNK in obesity and insulin resistance. Nature 420:333–336
-
(2002)
Nature
, vol.420
, pp. 333-336
-
-
Hirosumi, J.1
Tuncman, G.2
Chang, L.3
Görgün, C.Z.4
Uysal, K.T.5
Maeda, K.6
-
43
-
-
38049110692
-
Amyloid beta oligomers induce impairment of neuronal insulin receptors
-
COI: 1:CAS:528:DC%2BD1cXkslWntw%3D%3D, PID: 17720802
-
Zhao W-Q, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ et al (2008) Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J 22:246–260
-
(2008)
FASEB J
, vol.22
, pp. 246-260
-
-
Zhao, W.-Q.1
De Felice, F.G.2
Fernandez, S.3
Chen, H.4
Lambert, M.P.5
Quon, M.J.6
-
44
-
-
67650729973
-
β-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin
-
COI: 1:CAS:528:DC%2BD1MXovFegu74%3D, PID: 19605645
-
Ma Q-L, Yang F, Rosario ER, Ubeda OJ, Beech W, Gant DJ et al (2009) β-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29:9078–9089
-
(2009)
J Neurosci
, vol.29
, pp. 9078-9089
-
-
Ma, Q.-L.1
Yang, F.2
Rosario, E.R.3
Ubeda, O.J.4
Beech, W.5
Gant, D.J.6
-
45
-
-
84859726053
-
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
-
COI: 1:CAS:528:DC%2BC38Xlt1egtbc%3D, PID: 22476196
-
Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel J-C, Decker H et al (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers. J Clin Invest 122:1339–1353
-
(2012)
J Clin Invest
, vol.122
, pp. 1339-1353
-
-
Bomfim, T.R.1
Forny-Germano, L.2
Sathler, L.B.3
Brito-Moreira, J.4
Houzel, J.-C.5
Decker, H.6
-
46
-
-
84889656503
-
TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer’s β-amyloid oligomers in mice and monkeys
-
COI: 1:CAS:528:DC%2BC3sXhvFOlsrnM, PID: 24315369
-
Lourenco MV, Clarke JR, Frozza RL, Bomfim TR, Forny-Germano L, Batista AF et al (2013) TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer’s β-amyloid oligomers in mice and monkeys. Cell Metab 18:831–843
-
(2013)
Cell Metab
, vol.18
, pp. 831-843
-
-
Lourenco, M.V.1
Clarke, J.R.2
Frozza, R.L.3
Bomfim, T.R.4
Forny-Germano, L.5
Batista, A.F.6
-
47
-
-
60549084867
-
Protection of synapses against Alzheimer’s-linked toxins: insulin signaling prevents the pathogenic binding of Aβ oligomers
-
PID: 19188609
-
De Felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, Lambert MP et al (2009) Protection of synapses against Alzheimer’s-linked toxins: insulin signaling prevents the pathogenic binding of Aβ oligomers. Proc Natl Acad Sci 106:1971–1976
-
(2009)
Proc Natl Acad Sci
, vol.106
, pp. 1971-1976
-
-
De Felice, F.G.1
Vieira, M.N.2
Bomfim, T.R.3
Decker, H.4
Velasco, P.T.5
Lambert, M.P.6
-
48
-
-
34248190279
-
Aβ oligomers—a decade of discovery
-
COI: 1:CAS:528:DC%2BD2sXmsFensrc%3D, PID: 17286590
-
Walsh DM, Selkoe DJ (2007) Aβ oligomers—a decade of discovery. J Neurochem 101:1172–1184
-
(2007)
J Neurochem
, vol.101
, pp. 1172-1184
-
-
Walsh, D.M.1
Selkoe, D.J.2
-
49
-
-
79959341519
-
Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory and Aging Project
-
COI: 1:CAS:528:DC%2BC3MXosFChsLs%3D, PID: 21222592
-
Negash S, Bennett DA, Wilson RS, Schneider JA, Arnold SE (2011) Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory and Aging Project. Curr Alzheimer Res 8:336
-
(2011)
Curr Alzheimer Res
, vol.8
, pp. 336
-
-
Negash, S.1
Bennett, D.A.2
Wilson, R.S.3
Schneider, J.A.4
Arnold, S.E.5
-
50
-
-
0025987048
-
Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment
-
COI: 1:STN:280:DyaK387mtFOntw%3D%3D, PID: 1789684
-
Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R et al (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572–580
-
(1991)
Ann Neurol
, vol.30
, pp. 572-580
-
-
Terry, R.D.1
Masliah, E.2
Salmon, D.P.3
Butters, N.4
DeTeresa, R.5
Hill, R.6
-
51
-
-
11544279355
-
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins
-
COI: 1:STN:280:DyaK1c3mtlektQ%3D%3D, PID: 9600986
-
Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M et al (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448–6453
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 6448-6453
-
-
Lambert, M.P.1
Barlow, A.K.2
Chromy, B.A.3
Edwards, C.4
Freed, R.5
Liosatos, M.6
-
53
-
-
0042838303
-
Alzheimer’s disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
-
COI: 1:CAS:528:DC%2BD3sXntFyns78%3D, PID: 12925731
-
Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE et al (2003) Alzheimer’s disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci 100:10417–10422
-
(2003)
Proc Natl Acad Sci
, vol.100
, pp. 10417-10422
-
-
Gong, Y.1
Chang, L.2
Viola, K.L.3
Lacor, P.N.4
Lambert, M.P.5
Finch, C.E.6
-
54
-
-
77954835300
-
High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
-
COI: 1:CAS:528:DC%2BC3cXhtVeisbbF, PID: 20339023
-
Fukumoto H, Tokuda T, Kasai T, Ishigami N, Hidaka H, Kondo M et al (2010) High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J 24:2716–2726
-
(2010)
FASEB J
, vol.24
, pp. 2716-2726
-
-
Fukumoto, H.1
Tokuda, T.2
Kasai, T.3
Ishigami, N.4
Hidaka, H.5
Kondo, M.6
-
55
-
-
34248547813
-
Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases
-
COI: 1:CAS:528:DC%2BD2sXlt1Kqsrc%3D, PID: 17505973
-
Ferreira ST, Vieira MN, De Felice FG (2007) Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases. IUBMB Life 59:332–345
-
(2007)
IUBMB Life
, vol.59
, pp. 332-345
-
-
Ferreira, S.T.1
Vieira, M.N.2
De Felice, F.G.3
-
56
-
-
33847662852
-
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide
-
COI: 1:CAS:528:DC%2BD2sXotFKmtw%3D%3D, PID: 17245412
-
Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide. Nat Rev Mol Cell Biol 8:101–112
-
(2007)
Nat Rev Mol Cell Biol
, vol.8
, pp. 101-112
-
-
Haass, C.1
Selkoe, D.J.2
-
57
-
-
33846633336
-
Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease
-
COI: 1:CAS:528:DC%2BD2sXhs1Wrsbc%3D, PID: 17251419
-
Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M et al (2007) Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci 27:796–807
-
(2007)
J Neurosci
, vol.27
, pp. 796-807
-
-
Lacor, P.N.1
Buniel, M.C.2
Furlow, P.W.3
Clemente, A.S.4
Velasco, P.T.5
Wood, M.6
-
58
-
-
79952797861
-
Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers
-
PID: 21115476
-
Jurgensen S, Antonio LL, Mussi GE, Brito-Moreira J, Bomfim TR, De Felice FG et al (2011) Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers. J Biol Chem 286:3270–3276
-
(2011)
J Biol Chem
, vol.286
, pp. 3270-3276
-
-
Jurgensen, S.1
Antonio, L.L.2
Mussi, G.E.3
Brito-Moreira, J.4
Bomfim, T.R.5
De Felice, F.G.6
-
59
-
-
47049120422
-
Alzheimer’s disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
-
PID: 17403556
-
De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, Lacor PN et al (2008) Alzheimer’s disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers. Neurobiol Aging 29:1334–1347
-
(2008)
Neurobiol Aging
, vol.29
, pp. 1334-1347
-
-
De Felice, F.G.1
Wu, D.2
Lambert, M.P.3
Fernandez, S.J.4
Velasco, P.T.5
Lacor, P.N.6
-
60
-
-
34249672242
-
Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine
-
PID: 17308309
-
De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST et al (2007) Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:11590–11601
-
(2007)
J Biol Chem
, vol.282
, pp. 11590-11601
-
-
De Felice, F.G.1
Velasco, P.T.2
Lambert, M.P.3
Viola, K.4
Fernandez, S.J.5
Ferreira, S.T.6
-
61
-
-
71349085957
-
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer’s disease indicate possible resistance to IGF-1 and insulin signalling
-
COI: 1:CAS:528:DC%2BD1MXhsFGrsL3O, PID: 18479783
-
Moloney AM, Griffin RJ, Timmons S, O’Connor R, Ravid R, O’Neill C (2010) Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer’s disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 31:224–243
-
(2010)
Neurobiol Aging
, vol.31
, pp. 224-243
-
-
Moloney, A.M.1
Griffin, R.J.2
Timmons, S.3
O’Connor, R.4
Ravid, R.5
O’Neill, C.6
-
63
-
-
33845468713
-
Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications
-
COI: 1:CAS:528:DC%2BD28Xht1Cnt77P, PID: 17132977
-
Craft S (2006) Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications. Alzheimer Dis Assoc Disord 20:298–301
-
(2006)
Alzheimer Dis Assoc Disord
, vol.20
, pp. 298-301
-
-
Craft, S.1
-
64
-
-
70349744089
-
Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis
-
PID: 19777393
-
de la Monte SM, Longato L, Tong M, Wands JR (2009) Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. Curr Opin Investig Drugs 10:1049–1060
-
(2009)
Curr Opin Investig Drugs
, vol.10
, pp. 1049-1060
-
-
de la Monte, S.M.1
Longato, L.2
Tong, M.3
Wands, J.R.4
-
65
-
-
68949161708
-
Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer’s disease
-
PID: 19542621
-
de la Monte SM, Tong M (2009) Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer’s disease. J Alzheimers Dis 17:817–825
-
(2009)
J Alzheimers Dis
, vol.17
, pp. 817-825
-
-
de la Monte, S.M.1
Tong, M.2
-
66
-
-
33645960672
-
Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer’s disease
-
COI: 1:CAS:528:DC%2BD28Xjs1Kltb0%3D, PID: 16627931
-
Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer’s disease. J Alzheimers Dis 9:13–33
-
(2006)
J Alzheimers Dis
, vol.9
, pp. 13-33
-
-
Lester-Coll, N.1
Rivera, E.J.2
Soscia, S.J.3
Doiron, K.4
Wands, J.R.5
de la Monte, S.M.6
-
67
-
-
0028598190
-
Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats
-
COI: 1:CAS:528:DyaK2MXksVOgsrs%3D, PID: 7747600
-
Duelli R, Schröck H, Kuschinsky W, Hoyer S (1994) Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci 12:737–743
-
(1994)
Int J Dev Neurosci
, vol.12
, pp. 737-743
-
-
Duelli, R.1
Schröck, H.2
Kuschinsky, W.3
Hoyer, S.4
-
68
-
-
33748755428
-
Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer’s disease
-
PID: 16988486
-
de la Monte SM, Tong M, Lester-Coll N, Plater J, Michael Wands JR (2006) Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer’s disease. J Alzheimers Dis 10:89–109
-
(2006)
J Alzheimers Dis
, vol.10
, pp. 89-109
-
-
de la Monte, S.M.1
Tong, M.2
Lester-Coll, N.3
Plater, J.4
Michael, W.J.R.5
-
69
-
-
77953004836
-
Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration
-
PID: 20302640
-
Tong M, Longato L, de la Monte SM (2010) Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration. BMC Endocr Disord 10:4
-
(2010)
BMC Endocr Disord
, vol.10
, pp. 4
-
-
Tong, M.1
Longato, L.2
de la Monte, S.M.3
-
70
-
-
4644286910
-
Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease
-
COI: 1:CAS:528:DC%2BD2cXjvVCltr8%3D, PID: 15033922
-
Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z et al (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease. FASEB J 18:902–904
-
(2004)
FASEB J
, vol.18
, pp. 902-904
-
-
Ho, L.1
Qin, W.2
Pompl, P.N.3
Xiang, Z.4
Wang, J.5
Zhao, Z.6
-
71
-
-
84866357260
-
Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation
-
COI: 1:CAS:528:DC%2BC38Xhtlyqs73O, PID: 22627185
-
Gallagher J, Minogue A, Lynch M (2012) Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation. Neurodegener Dis 11:33–41
-
(2012)
Neurodegener Dis
, vol.11
, pp. 33-41
-
-
Gallagher, J.1
Minogue, A.2
Lynch, M.3
-
72
-
-
27744462921
-
Insulin effects on CSF norepinephrine and cognition in Alzheimer’s disease
-
COI: 1:CAS:528:DC%2BD2MXht1egsr3K, PID: 16298239
-
Watson G, Bernhardt T, Reger MA, Cholerton BA, Baker LD, Peskind ER et al (2006) Insulin effects on CSF norepinephrine and cognition in Alzheimer’s disease. Neurobiol Aging 27:38–41
-
(2006)
Neurobiol Aging
, vol.27
, pp. 38-41
-
-
Watson, G.1
Bernhardt, T.2
Reger, M.A.3
Cholerton, B.A.4
Baker, L.D.5
Peskind, E.R.6
-
73
-
-
40349091597
-
Intranasal insulin improves cognition and modulates β-amyloid in early AD
-
COI: 1:CAS:528:DC%2BD1cXhtFels70%3D, PID: 17942819
-
Reger M, Watson G, Green P, Wilkinson C, Baker L, Cholerton B et al (2008) Intranasal insulin improves cognition and modulates β-amyloid in early AD. Neurology 70:440–448
-
(2008)
Neurology
, vol.70
, pp. 440-448
-
-
Reger, M.1
Watson, G.2
Green, P.3
Wilkinson, C.4
Baker, L.5
Cholerton, B.6
-
74
-
-
77950352189
-
GLP-1 receptor stimulation reduces amyloid-β peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer’s disease
-
PID: 20308787
-
Li Y, Duffy KB, Ottinger MA, Ray B, Bailey JA, Holloway HW et al (2010) GLP-1 receptor stimulation reduces amyloid-β peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer’s disease. J Alzheimers Dis 19:1205–1219
-
(2010)
J Alzheimers Dis
, vol.19
, pp. 1205-1219
-
-
Li, Y.1
Duffy, K.B.2
Ottinger, M.A.3
Ray, B.4
Bailey, J.A.5
Holloway, H.W.6
|